发明名称 Antimalarial drug comprising alaremycin or derivative thereof as active ingredient
摘要 Provided is a preventive and/or therapeutic agent for malaria, comprising, as an active ingredient, 5-acetamido-4-oxo-5-hexenoic acid (Alaremycin) or a derivative thereof. A preventive and/or therapeutic agent for malaria is used which comprises, as an active ingredient, Alaremycin or a derivative thereof represented by formula (I) (wherein R1 represents a hydroxy group, an amino group, or a substituted or unsubstituted straight chain or branched alkoxy group or alkylamino group having 1 to 8 carbons; R2 represents hydrogen, a substituted or unsubstituted straight chain or branched alkyl group having 1 to 8 carbons, or a substituted or unsubstituted aromatic group having 4 to 10 carbons; and R3 represents hydrogen or a methyl group).;
申请公布号 US9295660(B2) 申请公布日期 2016.03.29
申请号 US201113883038 申请日期 2011.11.09
申请人 Tokyo Institute of Technology;SBI Pharmaceuticals Co., Ltd. 发明人 Wachi Masaaki;Sato Shigeharu;Tanaka Tohru;Takahashi Kiwamu
分类号 A61K31/197;A61K31/16;A61K31/221;A61K9/00;A61K9/107;A61K9/20 主分类号 A61K31/197
代理机构 King & Spalding LLP 代理人 Brivanlou Margaret B.;Serunian Leslie A.;King & Spalding LLP
主权项 1. A method of treating or preventing malaria in a subject in need thereof, comprising administering to the subject Alaremycin or a derivative thereof represented by Formula (I),wherein R1 represents a hydroxy group, an amino group, or a substituted or unsubstituted straight chain or branched alkoxy group or alkylamino group having 1 to 8 carbons; R2 represents hydrogen, a substituted or unsubstituted straight chain or branched alkyl group having 1 to 8 carbons, or a substituted or unsubstituted aromatic group having 4 to 10 carbons; and R3 represents hydrogen or a methyl group, or a pharmaceutically acceptable salt thereof, in an amount effective to treat or prevent malaria in the subject.
地址 Tokyo JP